Drug Trial Radar · NCT00107835
Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults
Last checked: Nov 20, 2026Latest source record: Jun 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
408
Actual
Start
May 2005
Primary completion
Sep 2005
Study completion Sep 2005
Sponsor
- Lead sponsor
- ZARS Pharma Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 11, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in adults. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.
Conditions
- Pain
Interventions
S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)Drug
S-Caine Peel comprising a 1:1 eutectic mixture of 7% lidocaine, and 7% tetracaine was applied topically. The study drug remained on the treatment area for 20-30 minutes for minor dermal procedures and 60 minutes for major dermal procedures
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse eventsTime frame: 20-30 minutes
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
International Dermatology Research Inc.
Miami, Florida
Midwest Cutaneous Research
Clinton Township, Michigan
Laser and Skin Surgery Center of New York
New York, New York
Tennessee Clinical Research Center
Nashville, Tennessee
Texas Dermatology Research Institute
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.